Novel CB1 receptor antagonist BAR-1 modifies pancreatic islet function and clinical parameters in prediabetic and diabetic mice

por Nava-Molina, Lesly, Uchida-Fuentes, Toyokazu, Ramos-Tovar, Héctor, Fregoso-Padilla, Martha, Rodríguez-Monroy, Marco Aurelio, Vega, Ana V., Navarrete-Vázquez, Gabriel, Andrade-Jorge, Erik, Villalobos-Molina, Rafael, Ortiz-Ortega, Ricardo, Vilches-Flores, Alonso
Publicado 2020